Jennifer A. Nelson - 22 Nov 2024 Form 3 Insider Report for Omega Therapeutics, Inc. (OMGAQ)

Role
Chief Scientific Officer
Signature
/s/ Jennifer A. Nelson
Issuer symbol
OMGAQ
Transactions as of
22 Nov 2024
Net transactions value
$0
Form type
3
Filing time
26 Nov 2024, 18:27:25 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OMGA Stock Option (Right to Buy) 22 Nov 2024 Common Stock 110,000 $1.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable with respect to 25% of the underlying shares on August 14, 2025 and in 12 equal quarterly installments thereafter such that the option will become fully vested and exercisable on August 14, 2028, subject to the Reporting Person's continued service to the Issuer through each such vesting date.